Telix Pharmaceuticals Limited
TLPPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $8,015,186 | $3,222,799 | $2,150,387 | $2,205,096 |
| - Cash | $710,346 | $123,237 | $116,329 | $22,037 |
| + Debt | $581,448 | $17,445 | $10,446 | $2,539 |
| Enterprise Value | $7,886,288 | $3,117,007 | $2,044,504 | $2,185,598 |
| Revenue | $783,207 | $502,547 | $160,096 | $7,596 |
| % Growth | 55.8% | 213.9% | 2,007.6% | – |
| Gross Profit | $509,678 | $314,390 | $29,337 | -$29,765 |
| % Margin | 65.1% | 62.6% | 18.3% | -391.9% |
| EBITDA | $98,233 | $22,966 | -$92,837 | -$70,073 |
| % Margin | 12.5% | 4.6% | -58% | -922.5% |
| Net Income | $49,919 | $5,211 | -$104,079 | -$80,510 |
| % Margin | 6.4% | 1% | -65% | -1,059.9% |
| EPS Diluted | 0.14 | 0.016 | -0.34 | -0.29 |
| % Growth | 769.6% | 104.7% | -17.2% | – |
| Operating Cash Flow | $43,029 | $23,884 | -$63,970 | -$59,328 |
| Capital Expenditures | -$34,032 | -$10,794 | -$13,861 | -$1,339 |
| Free Cash Flow | $8,997 | $13,090 | -$77,831 | -$60,667 |